Zeria Pharmaceutical Co., Ltd.
4559.T
Price:
$1997
Market Cap:
$88.03B
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-01-01
Stock Exchange
JPX
Ticker
4559.T
PE Ratio
[15.68]
ROE
[7.78%]
Current Ratio
[1.29]
Dividend Yield
[2.35%]
Enterprise Value
[106.43B]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Zeria Pharmaceutical Co., Ltd. (4559.T) is 106.43B
According to Zeria Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 106.43B. This represents a change of -9.96% compared to the average of 118.21B of the last 4 quarters.
Zeria Pharmaceutical Co., Ltd. (4559.T) Historical Enterprise Value (quarterly & annually)
How has 4559.T Enterprise Value performed in the past?
The mean historical Enterprise Value of Zeria Pharmaceutical Co., Ltd. over the last ten years is 124.10B. The current 106.43B Enterprise Value has changed 8.48% with respect to the historical average. Over the past ten years (40 quarters), 4559.T's Enterprise Value was at its highest in in the September 2018 quarter at 149.76B. The Enterprise Value was at its lowest in in the June 2016 quarter at 108.41B.
Average
124.10B
Median
124.41B
Minimum
108.95B
Maximum
137.07B
Zeria Pharmaceutical Co., Ltd. (4559.T) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Zeria Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.10%
Maximum Annual Enterprise Value = 137.07B
Minimum Annual Increase = -9.64%
Minimum Annual Enterprise Value = 108.95B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 117.06B | -2.14% |
| 2024 | 119.62B | -9.64% |
| 2023 | 132.38B | 4.67% |
| 2022 | 126.47B | -7.74% |
| 2021 | 137.07B | 10.80% |
| 2020 | 123.71B | -1.12% |
| 2019 | 125.11B | -5.96% |
| 2018 | 133.04B | 13.10% |
| 2017 | 117.63B | 7.96% |
| 2016 | 108.95B | -1.86% |
Zeria Pharmaceutical Co., Ltd. (4559.T) Average Enterprise Value
How has 4559.T Enterprise Value performed in the past?
The current Enterprise Value of Zeria Pharmaceutical Co., Ltd. (4559.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
123.02B
5-year avg
126.52B
10-year avg
124.10B
Zeria Pharmaceutical Co., Ltd. (4559.T) Enterprise Value vs. Peers
How is 4559.T’s Enterprise Value compared to its peers?
Zeria Pharmaceutical Co., Ltd.’s Enterprise Value is greater than KYORIN Holdings, Inc. (94.53B), greater than Mochida Pharmaceutical Co., Ltd. (68.28B), greater than ASKA Pharmaceutical Holdings Co.,Ltd. (62.10B), less than Menicon Co., Ltd. (161.94B), greater than Japan Lifeline Co., Ltd. (101.55B), greater than Eiken Chemical Co., Ltd. (79.27B), less than Kaken Pharmaceutical Co., Ltd. (107.56B), less than Nxera Pharma Co., Ltd. (112.87B), less than Qol Holdings Co., Ltd. (106.66B), less than Towa Pharmaceutical Co., Ltd. (358.24B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 94.53B | $85.14B | |
| 68.28B | $120.18B | |
| 62.10B | $54.75B | |
| 161.94B | $121.04B | |
| 101.55B | $107.62B | |
| 79.27B | $80.94B | |
| 107.56B | $148.82B | |
| 112.87B | $78.19B | |
| 106.66B | $85.95B | |
| 358.24B | $171.56B |
Build a custom stock screener for Zeria Pharmaceutical Co., Ltd. (4559.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zeria Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Zeria Pharmaceutical Co., Ltd. (4559.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Zeria Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zeria Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Zeria Pharmaceutical Co., Ltd. (4559.T)?
What is the 3-year average Enterprise Value for Zeria Pharmaceutical Co., Ltd. (4559.T)?
What is the 5-year average Enterprise Value for Zeria Pharmaceutical Co., Ltd. (4559.T)?
How does the current Enterprise Value for Zeria Pharmaceutical Co., Ltd. (4559.T) compare to its historical average?